HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Perri Selected Research

Drug Therapy (Chemotherapy)

11/2008Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
8/2001A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
7/2001Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Perri Research Topics

Disease

12Neoplasms (Cancer)
02/2016 - 05/2000
5Melanoma (Melanoma, Malignant)
02/2016 - 05/2000
4Neoplasm Metastasis (Metastasis)
03/2009 - 05/2000
4Sarcoma (Soft Tissue Sarcoma)
03/2009 - 12/2003
4Hyperthermia
05/2005 - 07/2003
3Neuroblastoma
10/2014 - 05/2000
3Breast Neoplasms (Breast Cancer)
11/2008 - 07/2001
3Carcinoma (Carcinomatosis)
03/2001 - 05/2000
2Peritoneal Neoplasms
02/2011 - 07/2003
1Ophthalmia Neonatorum
01/2018
1Trachoma
01/2018
1Eye Diseases (Eye Disease)
01/2018
1Keratitis
12/2017
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2017
1Macular Degeneration (Age-Related Maculopathy)
01/2017
1Retinal Diseases
01/2017
1Retinitis Pigmentosa (Pigmentary Retinopathy)
12/2016
1Exophthalmos (Proptosis)
06/2016
1Strabismus (Squint)
06/2016
1Necrosis
10/2014
1Uveal melanoma
12/2012
1Cardiotoxicity
11/2008
1Breast Diseases (Breast Disease)
07/2001
1Colonic Polyps
03/2001
1Colonic Neoplasms (Colon Cancer)
03/2001
1Colorectal Neoplasms (Colorectal Cancer)
03/2001

Drug/Important Bio-Agent (IBA)

6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 07/2003
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2009 - 12/2003
3Melphalan (Alkeran)FDA LinkGeneric
03/2009 - 07/2003
2Retinaldehyde (Retinal)IBA
01/2017 - 12/2016
2Liposomes (Liposome)IBA
10/2014 - 11/2004
2Antineoplastic Agents (Antineoplastics)IBA
05/2005 - 12/2003
2liposomal doxorubicin (Doxil)FDA Link
05/2005 - 11/2004
2Biomarkers (Surrogate Marker)IBA
08/2001 - 03/2001
2Carcinoembryonic AntigenIBA
08/2001 - 03/2001
1Clodronic Acid (Clodronate)IBA
02/2016
1Bortezomib (Velcade)FDA Link
10/2014
1TNF-Related Apoptosis-Inducing LigandIBA
10/2014
1Ruthenium-106IBA
12/2012
1Docetaxel (Taxotere)FDA Link
11/2008
1AnthracyclinesIBA
11/2008
1Trastuzumab (Herceptin)FDA Link
11/2008
1Coloring Agents (Dyes)IBA
03/2007
1Pharmaceutical PreparationsIBA
12/2003
1Cytostatic AgentsIBA
07/2003
1Tumor Biomarkers (Tumor Markers)IBA
07/2001
1tissue polypeptide specific antigenIBA
07/2001
1Messenger RNA (mRNA)IBA
03/2001
1Proteins (Proteins, Gene)FDA Link
03/2001
1Integrin alphaVbeta3IBA
05/2000
1Cancer VaccinesIBA
05/2000
1Interleukin-2 (IL2)IBA
05/2000

Therapy/Procedure

6Therapeutics
01/2018 - 05/2000
3Drug Therapy (Chemotherapy)
11/2008 - 07/2001
2Surgical Amputation (Amputations)
05/2005 - 12/2003
2Neoadjuvant Therapy
12/2003 - 07/2001
1Corneal Transplantation (Keratoplasty)
12/2017
1Sutures (Suture)
06/2016
1Decompression
06/2016
1Conservative Treatment
12/2012
1Brachytherapy
12/2012
1Hyperthermic Intraperitoneal Chemotherapy
02/2011
1Cytoreduction Surgical Procedures
02/2011
1Investigational Therapies (Experimental Therapy)
03/2001
1Immunotherapy
05/2000